Search Results for 'Exenatide-Glp'

Exenatide-Glp published presentations and documents on DocSlides.

Updates Abound Introduction

Updates Abound Introduction

by sherrill-nordquist

GLP-1 RAs in Combination With Basal Insulin Appro...

Modelling of GLP-1 and its analogues effect on food digesti

Modelling of GLP-1 and its analogues effect on food digesti

by alida-meadow

Veronika Voronova, Kirill . Zhudenkov. , Kirill ....

Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights from the EXSCEL Trial

Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights from the EXSCEL Trial

by relylancome

Robert J. Mentz, M. Angelyn Bethel, Peter Merrill,...

“Weighing” in on GLP-1 Receptor Agonists

“Weighing” in on GLP-1 Receptor Agonists

by priscilla

for People With HIV. Suman Srinivasa, MD, MS. Mass...

A Clinical Approach Utilizing GLP-1 RAs

A Clinical Approach Utilizing GLP-1 RAs

by udeline

Diabetes Management . for the Cardiologist. Confid...

Insulin/GLP-1 Agonist Combinations

Insulin/GLP-1 Agonist Combinations

by calandra-battersby

Program Overview. Pathophysiology of Hyperglycemi...

CV Outcomes and Adherence

CV Outcomes and Adherence

by ellena-manuel

With GLP-1 RAs. This program will include a discu...

GLP-1/Glucagon Dual Receptor Agonist ALT-801 is Superior to Semaglutide in Improving NASH Endpoint

GLP-1/Glucagon Dual Receptor Agonist ALT-801 is Superior to Semaglutide in Improving NASH Endpoint

by sophie

Biopsy-Confirmed DIO Mouse Model. JJ Nestor. 1. , ...

Psychiatry Meeting 24 th

Psychiatry Meeting 24 th

by layla

November 2016. Andrew Gallagher. Consultant Physic...

Chad Christianson Jason Watts Katherine Yahvah and Michael Williams

Chad Christianson Jason Watts Katherine Yahvah and Michael Williams

by mackenzie

OVERVIEW 4080120160200240280320360400440480Analyte...

BTUSPFOUFSPMPHZ3FTFBSDIBOE1SBDU

BTUSPFOUFSPMPHZ3FTFBSDIBOE1SBDU

by audrey

)JOEBXJ 7PMVNF\r"SUJ...

Current Therapy in Type 2 Diabetes:

Current Therapy in Type 2 Diabetes:

by Dragonlord

What Follows Metformin? . James R. Gavin III, MD, ...

F. Hosseinpanah Obesity Research Center

F. Hosseinpanah Obesity Research Center

by Outlawking

Research Institute for Endocrine sciences. Shahid....

Incretin -based therapies

Incretin -based therapies

by SoulfulDreamer

Part I. F. . Hosseinpanah. Obesity Research Center...

Genotoxicity and Industry:

Genotoxicity and Industry:

by deena

Utilizing genetic toxicity assays to . support pha...

Introduction to the GLPTN Program

Introduction to the GLPTN Program

by jocelyn

Network Overview. TCPI Program. The Transforming ....

A conserved dorsomedial hypothalamic population mediates leptin’s control of body weight

A conserved dorsomedial hypothalamic population mediates leptin’s control of body weight

by barbara

Alan C. Rupp. 1. , Abigail J. Tomlinson. 1. , Alis...

Shifting Paradigms in the Selection of

Shifting Paradigms in the Selection of

by alyssa

Antidiabetes. Medications:. Cardiovascular Benefi...

Figure Figure. Laboratory findings of hemorrhagic diathesis in an 18-year-old Somalian refugee to G

Figure Figure. Laboratory findings of hemorrhagic diathesis in an 18-year-old Somalian refugee to G

by yvonne

Keller C, Zumblick M, Streubel K, Eickmann M, Mül...

Oral hypoglycemics Jennifer R Marks, MD

Oral hypoglycemics Jennifer R Marks, MD

by finley

Oral hypoglycemics. Factors to consider:. Cost. Av...

TheemergingroleofFOXOtranscriptionfactorsinpancreaticDominiqueAGlauser

TheemergingroleofFOXOtranscriptionfactorsinpancreaticDominiqueAGlauser

by maisie

ForkheadbRZQORDGHGIURPLRVFLHQWLILFDFRPDW0YLDIUHHDF...

Overview of CVM Overview of CVM

Overview of CVM Overview of CVM

by della

1Overview of Overview of Clinical Investigator CIC...

Insulin and Incretins:

Insulin and Incretins:

by liane-varnes

Insulin and Incretins: the perfect Partnership? S...

The Influence of Type 2 Diabetes on Cardiovascular Disease

The Influence of Type 2 Diabetes on Cardiovascular Disease

by conchita-marotz

and Glycemic Treatment Options. Rocky . Mountain/...

GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D

GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D

by stefany-barnette

Program Goal. Case Presentation: Diane. Case Pres...

NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIES

NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIES

by alexa-scheidler

Prevalence of Adult Obesity: 2000 to Present. Cli...

SGLT-2 Inhibitor with Incretins

SGLT-2 Inhibitor with Incretins

by pamella-moone

Add on to insulin. EFFICACY AND TOLERABILITY. OF ...

Psychiatry Meeting

Psychiatry Meeting

by myesha-ticknor

24. th. November 2016. Andrew Gallagher. Consult...

Global Learning

Global Learning

by pasty-toler

T. ask – . -Please go through the slides and fo...

Current Status of Incretin Based

Current Status of Incretin Based

by min-jolicoeur

Therapies in Type 2 Diabetes. DR.M.Mukhyaprana. ...

A A partnership between Rotary clubs and CoEd

A A partnership between Rotary clubs and CoEd

by olivia-moreira

to promote literacy in Guatemala. 449 . Rotary . ...

Supporting people living with diabetes to achieve better outcomes: Impact of the ABCD audit program

Supporting people living with diabetes to achieve better outcomes: Impact of the ABCD audit program

by kylie

Dr Bob Ryder and Dr Emma Wilmot. Diabetes UK Prof...

The Day Before and Day of Surgery or Procedure

The Day Before and Day of Surgery or Procedure

by blanko

A Guide to Diabetes Medications 1. Find the presc...

New Insights from EXSCEL

New Insights from EXSCEL

by pongre

M. Angelyn Bethel, MD. Associate Professor of Diab...

Advances in Diabetes Joseph A. Aloi, MD, FACP, FACE

Advances in Diabetes Joseph A. Aloi, MD, FACP, FACE

by mentegor

Associate Professor of Medicine. Clinical Director...

Updates on CVOT Data and Clinical Comparisons That Matter

Updates on CVOT Data and Clinical Comparisons That Matter

by pamella-moone

This program will include a discussion of off-lab...

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

by caleb954

James L. Januzzi Jr, . MD. a. , Javed Butler, MD, ...

Follow your doctor`s prescription; the timing and dose (units or

Follow your doctor`s prescription; the timing and dose (units or

by angelo145

quantity) of injection is extremely important. (. ...

Newer Glucose Lowering Medications:

Newer Glucose Lowering Medications:

by lily

Agent-Specific Considerations. Joshua J. Neumiller...

A selection of published clinical data was used that included

A selection of published clinical data was used that included

by pagi

various, non-pharmacological challenges to glucose...